Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D002997:Clomipramine / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D003984:Dibenzazepines / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000032:analysis; D008297:Male; D008376:Maprotiline / Q000627:therapeutic use*; D008734:Methoxyhydroxyphenylglycol / Q000032:analysis; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales
D000873:Anthracenes; D003984:Dibenzazepines; D008376:Maprotiline; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D002997:Clomipramine